244 related articles for article (PubMed ID: 27115175)
61. Ruthenium(II) polypyridyl complexes as G-quadruplex inducing and stabilizing ligands in telomeric DNA.
Yu Q; Liu Y; Zhang J; Yang F; Sun D; Liu D; Zhou Y; Liu J
Metallomics; 2013 Mar; 5(3):222-31. PubMed ID: 23407741
[TBL] [Abstract][Full Text] [Related]
62. Naphthalene diimide-derivatives G-quadruplex ligands induce cell proliferation inhibition, mild telomeric dysfunction and cell cycle perturbation in U251MG glioma cells.
Muoio D; Berardinelli F; Leone S; Coluzzi E; di Masi A; Doria F; Freccero M; Sgura A; Folini M; Antoccia A
FEBS J; 2018 Oct; 285(20):3769-3785. PubMed ID: 30095224
[TBL] [Abstract][Full Text] [Related]
63. G-quadruplexes as therapeutic targets.
Neidle S; Read MA
Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
[TBL] [Abstract][Full Text] [Related]
64. A platinum supramolecular square as an effective G-quadruplex binder and telomerase inhibitor.
Kieltyka R; Englebienne P; Fakhoury J; Autexier C; Moitessier N; Sleiman HF
J Am Chem Soc; 2008 Aug; 130(31):10040-1. PubMed ID: 18616250
[TBL] [Abstract][Full Text] [Related]
65. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
66. Synthesis and biological evaluation of disubstituted amidoxanthones as potential telomeric G-quadruplex DNA-binding and apoptosis-inducing agents.
Shen R; Chen Y; Li Z; Qi H; Wang Y
Bioorg Med Chem; 2016 Feb; 24(4):619-26. PubMed ID: 26740156
[TBL] [Abstract][Full Text] [Related]
67. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
[TBL] [Abstract][Full Text] [Related]
68. Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure.
Rezler EM; Seenisamy J; Bashyam S; Kim MY; White E; Wilson WD; Hurley LH
J Am Chem Soc; 2005 Jul; 127(26):9439-47. PubMed ID: 15984871
[TBL] [Abstract][Full Text] [Related]
69. Investigating the Effect of Mono- and Dimeric 360A G-Quadruplex Ligands on Telomere Stability by Single Telomere Length Analysis (STELA).
Hwang IP; Mailliet P; Hossard V; Riou JF; Bugaut A; Roger L
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736276
[TBL] [Abstract][Full Text] [Related]
70. DNA loop sequence as the determinant for chiral supramolecular compound G-quadruplex selectivity.
Yu H; Zhao C; Chen Y; Fu M; Ren J; Qu X
J Med Chem; 2010 Jan; 53(1):492-8. PubMed ID: 19911822
[TBL] [Abstract][Full Text] [Related]
71. High in vivo antitumor activity of cobalt oxoisoaporphine complexes by targeting G-quadruplex DNA, telomerase and disrupting mitochondrial functions.
Qin QP; Qin JL; Meng T; Lin WH; Zhang CH; Wei ZZ; Chen JN; Liu YC; Liang H; Chen ZF
Eur J Med Chem; 2016 Nov; 124():380-392. PubMed ID: 27597414
[TBL] [Abstract][Full Text] [Related]
72. Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
Streciwilk W; Terenzi A; Cheng X; Hager L; Dabiri Y; Prochnow P; Bandow JE; Wölfl S; Keppler BK; Ott I
Eur J Med Chem; 2018 Aug; 156():148-161. PubMed ID: 30006161
[TBL] [Abstract][Full Text] [Related]
73. Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures.
Doria F; Nadai M; Folini M; Di Antonio M; Germani L; Percivalle C; Sissi C; Zaffaroni N; Alcaro S; Artese A; Richter SN; Freccero M
Org Biomol Chem; 2012 Apr; 10(14):2798-806. PubMed ID: 22367401
[TBL] [Abstract][Full Text] [Related]
74. Indolo[3,2-c]quinoline G-quadruplex stabilizers: a structural analysis of binding to the human telomeric G-quadruplex.
Lavrado J; Ohnmacht SA; Correia I; Leitão C; Pisco S; Gunaratnam M; Moreira R; Neidle S; Santos DJ; Paulo A
ChemMedChem; 2015 May; 10(5):836-49. PubMed ID: 25820698
[TBL] [Abstract][Full Text] [Related]
75. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
[TBL] [Abstract][Full Text] [Related]
76. Stabilization of G-quadruplex DNA, inhibition of telomerase activity, and tumor cell apoptosis by organoplatinum(II) complexes with oxoisoaporphine.
Chen ZF; Qin QP; Qin JL; Liu YC; Huang KB; Li YL; Meng T; Zhang GH; Peng Y; Luo XJ; Liang H
J Med Chem; 2015 Mar; 58(5):2159-79. PubMed ID: 25650792
[TBL] [Abstract][Full Text] [Related]
77. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
[TBL] [Abstract][Full Text] [Related]
78. Aromatic core extension in the series of N-cyclic bay-substituted perylene G-quadruplex ligands: increased telomere damage, antitumor activity, and strong selectivity for neoplastic over healthy cells.
Franceschin M; Rizzo A; Casagrande V; Salvati E; Alvino A; Altieri A; Ciammaichella A; Iachettini S; Leonetti C; Ortaggi G; Porru M; Bianco A; Biroccio A
ChemMedChem; 2012 Dec; 7(12):2144-54. PubMed ID: 23097341
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.
Laronze-Cochard M; Kim YM; Brassart B; Riou JF; Laronze JY; Sapi J
Eur J Med Chem; 2009 Oct; 44(10):3880-8. PubMed ID: 19467742
[TBL] [Abstract][Full Text] [Related]
80. Structure-based design and evaluation of naphthalene diimide G-quadruplex ligands as telomere targeting agents in pancreatic cancer cells.
Micco M; Collie GW; Dale AG; Ohnmacht SA; Pazitna I; Gunaratnam M; Reszka AP; Neidle S
J Med Chem; 2013 Apr; 56(7):2959-74. PubMed ID: 23514618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
